Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors



Rating:

Share or cite this content

Citations should be made in the following way:
V. Antonov (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), G. Ignatova (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), S. Zotov (Chelyabinsk (Chelyabinsk Oblast), Russian Federation). Experience of olokizumab use in COVID-19 patients. 817

Member's Comments

No comment yet.

Related content which might interest you: Experience of Bedaquiline use in treatment of XDR-TB patients Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017 Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003 Use of antidepressive agents in COPD patients: experience in a large Canadian cohort Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Clinical experience in surgical therapy of 184 patients with bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 626s Year: 2004 Clinical experience in surgical therapy of 257 patients with bronchiectasis Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology Year: 2007 Experience with alternative medicine in Saudi asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 259s Year: 2003 Indications of NIV use for COVID-infected patients Source: COVID-19 Videos Year: 2020 Effectiveness of rehabilitation in patients with asthma Source: Annual Congress 2008 - Models of pulmonary rehabilitation in non-COPD patients Year: 2008 Long-term effectiveness of surgery treatment of TB patients Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Our clinical experience in surgical therapy of patients with bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 344s Year: 2002 Evaluation of the effectiveness of an outpatient rehabilitation course for patients previously hospitalised with COVID-19 Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Effectiveness of a telemanagement system for home follow-up of severe respiratory patients - the Italian experience Source: Eur Respir J 2002; 20: Suppl. 38, 156s Year: 2002 Effectiveness of combined therapy in patients with brittle asthma Source: Eur Respir J 2002; 20: Suppl. 38, 512s Year: 2002 Assessment and therapy for COPD patients in real-life primary care Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 Combination therapy versus separate therapy in real-life primary care asthma patients Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 Late Breaking Abstract - Severe pneumonia patients may could not benefit from antibiotic combination therapy and non-invasive ventilation(NIV), despite the advanced mode Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 Assessment of antibiotic prescribing practises for hospitalised patients with suspected sepsis using a score of "likelihood of infection" Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009